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BmpProstaglandins are a group of lipid signaling molecules involved in various physiological processes. In addition,
prostaglandins have been implicated in the development and progression of diseases including cancer,
cardiovascular disease, and arthritis. Prostaglandins exert their effects through the activation of speciﬁc G
protein-coupled receptors (GPCRs). In this report, we examined the role of prostaglandin F2α receptor (FP)
signaling as a regulator of chondrocyte differentiation. We found that FP expression was dramatically induced
during the differentiation of chondrocytes and was up-regulated in cartilages. Forced expression of FP in
ATDC5 chondrogenic cell line resulted in the increased expression of differentiation-related genes and increased
synthesis of the extracellular matrix (ECM) regardless of the presence of insulin. Similarly, PGF2α treatment
induced the expression of chondrogenic marker genes. In contrast, knockdown of endogenous FP expression
suppressed the expression of chondrocytemarker genes and ECM synthesis. Organ culture of cartilage rudiments
revealed that PGF2α induces chondrocyte hypertrophy. Additionally, FP overexpression increased the levels of
Bmp-6, phospho-Smad1/5, and Bmpr1a, while knockdown of FP reduced expression of those genes. These results
demonstrate that up-regulation of FP expression plays an important role in chondrocyte differentiation and
modulates Bmp signaling.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Chondrogenic differentiation is a key process in endochondral
ossiﬁcation which occurs during the development, growth, and repair
of the skeleton. During endochondral ossiﬁcation, the condensed
mesenchymal cells differentiate into chondrocytes to form the cartilage
anlagen. Chondrocytes rapidly proliferate and synthesize cartilage
extracellularmatrix (ECM) such as collagen type II (Col2A1) andaggrecan
(Acan1) [1,2]. The chondrocytes then cease proliferation and enlarge by
several folds, becoming hypertrophic chondrocytes. Hypertrophic
chondrocytes are characterized by the expression of collagen type X
(Col10A1) and matrix metalloproteinase 13 (Mmp13) [2–4]. Hypertro-
phic chondrocytes mineralize the surrounding matrix and secrete
vascular endothelial growth factor (VEGF) for blood vessel formation.
Eventually, these cells die by apoptosis and are replaced by osteoblasts
that form trabecular bone. The differentiation of chondrocytes through
the process of endochondral ossiﬁcation is regulated by many growth
factors and signaling molecules. One of the signaling molecules
implicated in this process is prostaglandins.l Sciences, University of South
PSC), SC, USA. Tel.: +1 803 777Prostaglandins are a class of bioactive lipid signaling molecules,
consisting of prostaglandin D2 (PGD2), prostaglandin E2 (PGE2),
prostaglandin F2α (PGF2α), and prostacyclin (PGI2). They are generated
from arachidonic acid by the sequential actions of cyclooxygenase
(COX) and its respective prostaglandin synthases. Prostaglandins exert
their effects through their interactions with speciﬁc cell surface recep-
tors, which are G protein-coupled receptors (GPCRs). Prostaglandin
receptors are classiﬁed on the basis of their response to a particular
prostaglandin: PGD2 to DP, PGE2 to EP, PGF2α to FP, and PGI2 to IP.
They are expressed in variable levels among different tissues and their
expression is regulated by various physiological and pathological
stimuli [5], providing an additional level of regulation in prostaglandin
signaling. For example, LPS treatment highly induced the expressions
of EP2 and EP4 receptors [6,7] in macrophages and these inductions
were suggested to be involved in the regulation of TNF-α [8]. In
addition, the overexpression of the EP2 receptor in the epidermis
of EP2 transgenic mice resulted in enhanced skin tumor formation,
proliferation, and blood vessel formation [9].
Prostaglandins regulate cartilage metabolism and are implicated in
the pathogenesis of osteoarthritis (OA) and rheumatoid arthritis (RA).
In addition to PGE2, PGF2α is a major prostaglandin in the synovial
ﬂuid of joints [10]. However, only a few studies have suggested the
role of PGF2α in cartilagemetabolism and pathologywhilemany studies
investigating the effects of prostaglandins on chondrocyte physiology
have focused on PGE2 signaling. PGF2α stimulated aggrecan synthesis
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Col2A1 mRNA in human articular chondrocytes [12]. Moreover, the
levels of PGE2 andPGF2α are signiﬁcantly increased in blood and synovial
ﬂuid samples from OA or RA patients [10]. The biological effect of PGF2α
is mediated by FP. Upon binding to PGF2α, FP activates the Gq protein,
which in turn increases the levels of inositol triphosphate (IP3)/
diacylglycerol (DAG) [13]. FP expression has been recently reported in
hypertrophic chondrocytes of growth plate cartilage [14], suggesting
that FP signalingmay be involved in chondrocyte hypertrophy.However,
the expression and the role of FP in cartilage development and diseases
have not been clearly determined.
In the present study,we investigated the role of FP signaling in chon-
drocyte differentiation. We found that FP expression is highly induced
during chondrogenesis. We demonstrated that FP signaling stimulates
and is required for chondrogenic differentiation. Moreover, our study
suggests a possible cross-talk between FP and Bmp signaling pathways.
2. Materials and methods
2.1. Cell culture and treatment
ATDC5 cell linewas purchased fromAbgent (San Diego, CA) andwas
maintained in DMEM/Ham's F-12 medium (GIBCO®, Grand Island, NY)Fig. 1. Prostaglandin F2α receptor (FP) mRNA is highly induced during chondrogenic differentia
differentiation of ATDC5 cell line. ATDC5 cells were induced to differentiate in the presence of
conducted. RNA from themouse kidney and colonwere used as a positive control (+). DPwas
chondrogenic differentiation of ATDC5 cells (left panel) (n=3, **: p b 0.01, ***: p b 0.001). The l
ImageJ software. The relative level of FP was plotted (right panel) (n = 3, *: p b 0.05, ***: p b
chondrogenic differentiation of C3H10T1/2 cell line (left panel). The expression level of FP at e
(right panel). (D) RT-PCR analysis for FP expression in various tissues of 4 weeks old C57BL/6with 5% FBS (GIBCO®, Grand Island, NY), 10 μg/ml human transferrin
(Sigma Chemical, St Louis, MO), 3 × 10−8 M sodium selenite (Sigma
Chemical, St Louis, MO), 50 units/ml penicillin, and 50 mg/ml strepto-
mycin (GIBCO®, Grand Island, NY). For induction of chondrogenic
differentiation, the cells were plated in a 2 × 105 cells/60 mm plate.
The next day, 10 μg/ml bovine insulin (Sigma Chemical, St Louis, MO,)
supplementation was started, as previously described [15]. The ATDC5
cells were treated with 100 nM PGF2α (Cayman chemical, Ann Arbor,
MI) for the indicated days and the media with PGF2α was replaced
every 2nd day. C3H10T1/2 cell line was purchased from American
Type Culture Collection (ATCC, Manassas, VA) and maintained in
DMEM medium (GIBCO®, Grand Island, NY) with 10% FBS (GIBCO®,
Grand Island, NY), 50 units/ml penicillin and 50 mg/ml streptomycin
(GIBCO®, Grand Island, NY) and micromass cultured with recombinant
humanBmp2 (Sigma Chemical, St Louis,MO) for the indicated days [16].
2.2. Metatarsal organ culture and treatment
Themetatarsal cartilage rudiments were isolated from the hind limb
of the E15.5 stage C57BL/6 mouse fetus, and cultured in organ culture
medium containing serum free DMEM with 50 μg/ml ascorbic acid,
300 μg/ml L-glutamine, 1 mM β-glycerophosphate, 0.2% BSA Cohn
fraction V (Sigma Chemical, St Louis, MO), 50 units/ml penicillin, andtion of the ATDC5 cell line. (A) Expression of prostaglandin receptors during chondrogenic
10 μg/ml insulin. RNA was isolated at the indicated time points and RT-PCR analysis was
not detected in any sample. (B) RT-PCR analysis of FP, Col2A1, Col10A1, and β-actin during
evel of FPmRNA at each time point was quantiﬁed and normalized to β-actinmRNA using
0.001). (C) RT-PCR analysis of FP, Col2A1, Col10A1, and β-actin during Bmp2-induced
ach time point was normalized to the β-actin level and the relative level of FP was plotted
mouse. 18 s rRNA served as a loading control.
Fig. 2. Stimulation of FP signaling promotes chondrocyte differentiation. (A) Western blot analysis for FLAG-tagged mouse FP. Total lysates from control (EGFP) and FP over-expressing
(FP) ATDC5 cells were probed for FLAG. The membrane was stripped and reprobed for β-actin to conﬁrm equal loading. (B, C, and D) The control and FP over-expressing ATDC5 cells
were cultured in the presence of insulin and then the expression level of Col2A1 (B), Col10A1(C), and Mmp13 (D) at each time point was analyzed by quantitative real time PCR (qRT-
PCR). The expression levels of marker genes were normalized to β-actin. Data were expressed as fold changes over control (EGFP) cells at day 0. The data represent the mean ± S.E.M.
of three independent experiments (***: p b 0.001). (E, F, and G) The control and FP over-expressing ATDC5 cell lines were cultured for the indicated time points without insulin
supplementation. The expression levels of Col2A1 (E), Col10A1 (F), and Mmp13 (G) were analyzed by qRT-PCR. The expression levels of marker genes were normalized to β-actin.
Data were expressed as fold change over control (EGFP) cells at day 0. The data represent the mean ± S.E.M. of three independent experiments (***: p b 0.001). (H) Alcian blue staining
of control and FP over-expressing ATDC5 cells at day 12 of culture without insulin supplement (left panel). The relative intensities of alcian blue staining in control and FP stable cell lines
weremeasured by dissolving alcian blue stained cells with 6M guanidine solution. The optical density at 630 nmwas plotted (***: p b 0.001) (right panel). (I) Effects of PGF2a on the levels
of chondrogenic marker. ATDC5 cells were treated with either vehicle or 100 nM PGF2a for 7 days. Expression of Acan1, Col2A1, and Col10A1 mRNAs was quantiﬁed by qRT-PCR. The
expression levels of marker genes were normalized to β-actin. Data were expressed as fold change over vehicle treated cells. The data represent the mean ± S.E.M. of three independent
experiments (**: p b 0.01, ***: p b 0.001).
502 J. Kim, M. Shim / Biochimica et Biophysica Acta 1853 (2015) 500–512
Fig. 3. Knockdown of endogenous FP expression suppresses chondrogenic differentiation. (A) The relative FP expression in ATDC5 cells infectedwith the empty vector- or FP shRNA-encoding
(FP shRNA #1 and #2) lentivirus at day 12 of insulin-induced chondrogenic differentiation was analyzed by qRT-PCR and normalized to β-actin. The expression levels of FP and β-actin in FP
shRNA cell lines were also determined by RT-PCR (gel image under graph A). (B, C, and D) ThemRNA levels of (B) Col2A1, (C) Col10A1, and (D)Mmp13 in FP knockdown cells (FP shRNA #1
and#2)weredeterminedbyqRT-PCR (upper panel). The relative gene expressionwasnormalized toβ-actin. Datawere expressed as fold changeover the control cell line. The expression levels
of Col2A1, Col10A1, and Mmp13 were also determined by RT-PCR (lower panel). (E) Alcian blue staining of control (empty) and FP knockdown (FP shRNA #1) ATDC5 cells cultured in the
presence of 10 μg/ml insulin for 15 days. The intensities of alcian blue staining in control and FP knockdown cell lines at 630nmwere plotted (right panel) (*: pb 0.05, **:pb 0.01, ***: pb 0.001).
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previously [17]. The next day, the cartilage rudiments were treated
with 100 nM PGF2α (Cayman Chemical, Ann Arbor, MI) for 6 days.
The media with PGF2α was replaced every 2nd day.. 4. PGF2α enhances ex vivo differentiation of hypertrophic chondrocytes in metatarsal cartilage
tatarsal cartilage rudiments. Themetatarsal cartilage rudimentswere cultured in thepresence o
ne (HZ)were denoted in the image. The inset shows the lowermagniﬁcation image of the rudim
niﬁcant difference in total length between vehicle- and PGF2α-treated cartilages (n= 5 per eac
tilage rudiment is presented on the graph (n=5 per each treatment group, **: p b 0.01). (D) Im
hicle or 100 nMPGF2α for 6 days. Lowermagniﬁcation images are shown in the upper panel. The
the upper image. (E) The ratio of the Col10A1 stained region to the total area was presented o
ining of Mmp13 in metatarsal cartilage rudiments treated with vehicle or 100 nM PGF2α for
resents a higher magniﬁcation image of the area marked with a bracket on the upper image.2.3. Establishment of stable and knockdown cell lines by lentiviral vector
The HEK 293T/17 cell was used as a packaging cell line and was
transfected with lentiviral packaging vectors and a target vector. Torudiments. (A) H&E staining of vehicle (A, left panel) or PGF2α (A, right panel) treated
f 100nMPGF2a for 6 days. The resting and proliferating zone (RZ&PZ) and hypertrophic
ent. (B) The total length of the cartilage rudiment is plotted on the graph. Therewas no
h treatment group, ns = no signiﬁcance). (C) The ratio of the HZ to the total length o
munohistochemical staining of Col10A1 inmetatarsal cartilage rudiments treatedwith
lower panel represents a highermagniﬁcation image of the areamarkedwith a bracke
n the graph (n= 5 per each treatment group, *: p b 0.05). (F) Immunohistochemica
6 days. Lower magniﬁcation images are shown in the upper panel. The lower panef
t
l
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sequence (NM_008966.3) was cloned from mouse cartilage cDNA
by PCR ampliﬁcation into pHAGE vector with a ﬂag tag. To generate a
FP knockdown cell line, target shRNA sequences of FP were designed
by web-based shRNA sequence designing software (http://www.
broadinstitute.org/rnai/public/seq/search). The sequences of FP shRNA
oligomers are listed in Table 3 of Supplementary information. TheFig. 5. FP signaling regulates Bmp expression. (A and B) qRT-PCR analysis of Bmp-4 (A) and Bm
ATDC5 cells. The control and FP over-expressing ATDC5 cell lines were cultured for the indicate
(EGFP) cells at day 0. The data represent the mean ± S.E.M. of three independent experiments
**: p b 0.01, ***: p b 0.001). (C and D) The control (EGFP) and FP over-expressing ATDC5 cell lin
for 7 days. Col2A1 (C) and Col10A1 (D) mRNA levels were determined by qRT-PCR analysis. D
the mean ± S.E.M. of three independent experiments. The fold change of respective genes wa
F) qRT-PCR analysis of Bmp-4 (E) and Bmp-6 (F) during insulin-induced chondrogenic differen
were induced to differentiate in the presence of 10 μg/ml insulin. Data were expressed as fo
three independent experiments and were analyzed by two-way ANOVA followed by the Bonfeviral particles were harvested after 48 h and were then incubated
with ATDC5 host cell line culture with polybrene for the next 48 h. In
shRNA lentiviral vector (pLBIP), the target sequence of FP was co-
expressed with EGFP by an internal ribosome entry site (IRES) and an
efﬁciency of lentiviral infection was assessed by EGFP ﬂuorescence
under microscope. The transfected cells were selected and maintained
in selective antibiotic (puromycin, 2 μg/ml) containing media.p-6 (B) during chondrogenic differentiation of control (EGFP) and FP over-expressing (FP)
d timewithout insulin supplementation. Data were expressed as fold changes over control
and were analyzed by two-way ANOVA followed by the Bonferroni posttest (*: p b 0.05,
es were cultured in insulin-free media in the absence or presence (2 μM) of dorsomorphin
ata were expressed as fold changes over control (EGFP) cells at day 0. The data represent
s compared by t-test and it was signiﬁcantly different (**: p b 0.01, ***: p b 0.001). (E and
tiation of control (empty) and FP knock-down (FP shRNA #1) ATDC5 cell lines. The cells
ld changes over control (empty) cells at day 0. The data represent the mean ± S.E.M. of
rroni posttest (*: p b 0.05, **: p b 0.01).
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PCR
Total RNA was extracted by using a RNeasy RNA extraction kit
(QIAGEN, Valencia, CA) according to the manufacturer's instructions.
2 μg of total RNA was used for the reverse transcription reaction using
MMLV reverse transcriptase (Promega, Madison, WI). The resulting
cDNA was diluted 1:3 in nuclease-free water and stored in aliquots at
−80 °C until used. For RT-PCR analysis of target genes, an initial ampli-
ﬁcation was done with a denaturation step at 95 °C for 3 min, followed
by denaturation at 95 °C for 30 s, primer annealing at 58 °C for 30 s, and
primer extension at 72 °C for 30 s. The primer sequences are provided in
Supplementary Table 1. Upon completion of the cycling steps, a ﬁnal
extension was performed at 72 °C for 7 min. Quantitative real-time
PCR analysis was conducted using a GoTaq® qPCR mixture (Promega,
Madison, WI). Reactions were run in triplicate for three independent
experiments. The mean of housekeeping gene β-actin was used as an
internal control to normalize the variability in expression levels.
The primer sequences for real-time PCR analysis are provided in
Supplemental Table 2. Expression data were normalized to the mean
of β-actin to control the variability in expression levels and were
analyzed using the 2−ΔΔCT method.
2.5. Protein extraction and Western blot analysis
Total protein was extracted with RIPA buffer [20 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1%
sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM β-
glycerophosphate, 1 mM sodium vanadate, 1 μg/ml leupeptin)] and
was used forWestern blot analysis. The 20 μg of extracted total proteins
was separated in SDS-PAGE gel and transferred onto PVDF membrane
(Millipore, Billerica, MA). Following incubation in blocking buffer (TBS
with 5% nonfat dry milk and 0.1% Tween 20) for 1 h at room tempera-
ture, the membrane was incubated at 4 °C overnight with various
primary antibodies; Flag (#2368, Cell Signaling, Boston, MA), phospho-
Smad1/5 (#9516, Cell Signaling, Boston, MA), phospho-Smad2
(#3101, Cell Signaling, Boston, MA), Smad1 (#9743, Cell Signaling,
Boston, MA), Smad2 (#3103, Cell Signaling, Boston, MA), and Bmpr1a
(#ABD51, Millipore, Billerica, MA). HRP-labeled secondary antibody
was used according to the host species of the primary antibody. West-
ern blotswere developed using ECL substrate and exposed to X-rayﬁlm.
2.6. Alcian blue staining and measurement of staining intensity
The differentiated cell lines were ﬁxed with Kahle's ﬁxative at room
temperature for 10 min. After ﬁxation, the cells were washed with
PBS and stained with 1% alcian blue stain 8-GX at room temperature
overnight. The cells were de-stained by washing with distilled water
and observed under an Olympus CXX41 microscope (Olympus, Center
Valley, PA). To measure the intensity of the alcian blue staining, the
stained cells were incubated with 6 M guanidine solution for 30 min
at room temperature on an orbital shaker. Absorbance was detected
by Synergy™ HT Multidetection Microplate Readers (BioTek™,
Winooski, VT) at a wavelength of 630 nm.
2.7. Morphological analysis and immunohistochemistry of metatarsal
cartilage rudiments
PGF2α- or vehicle-treated metatarsal cartilage rudiments were
ﬁxed overnight in 4% paraformaldehyde at 4 °C. On the next day, the
metatarsal cartilages were washed with 1x PBS for 2 min three times
and then were embedded in parafﬁn. The sections were cut 5 μm thick
and were used for morphological analysis by hematoxylin and eosin
(H&E) staining by standard protocols. To measure the length of each
cartilage zone, the images of sampleswere analyzed by ImageJ software
[18]. For the immunohistochemical staining, the 5 μm thick sectionsfrom PGF2α- or vehicle-treated metatarsal rudiments were incubated
with 3%H2O2 inmethanol for 15min at room temperature to deactivate
endogenous peroxidase activity. The antigen retrieval was done by heat
antigen retrieval in citrate buffer (10 mM sodium citrate buffer, pH 6.0)
for 30 min. To prevent nonspeciﬁc binding, the sections were blocked
with normal horse serum and incubated at room temperature for
30 min. The anti-Col10A1 (#234196, Calbiochem, San Diego, CA),
Mmp13 (#AB8120, Millipore, Billerica, MA), and phospho-Smad1/5
(#9511, Cell Signaling, Boston, MA) primary antibodies were incubated
at 4 °C, overnight. After three washings in 1x TBST (15 min each), the
sections were incubated with secondary antibody (ImmPRESS anti-
mouse Ig/anti-rabbit Ig, peroxidase Detection Kit, VECTOR, Burlingame,
CA) at room temperature for 30 min and washed with 1x TBST three
times (15 min each). The immunoreactivity was visualized by DAB
peroxidase substrate (VECTOR, Burlingame, CA). For morphometric
analysis, the stained sections were photographed under the Olympus
BX51microscope (Olympus, Center Valley, PA). The imagewas acquired
by an AxioCam MRc camera and analyzed by AxioVision AC Rel. 4.5
software (Carl Zeiss, Thornwood, NY).
2.8. Statistical analysis
p-Values were calculated by unpaired Student's t-tests and one- or
two-way analysis of variance (ANOVA) followed by the Bonferroni post-
test. p b 0.05 was considered signiﬁcant and was denoted in the graph
(*: p b 0.05, **: p b 0.01, and ***: p b 0.001). Statistical analysis was
performed using Prism software (Graphpad Software, La Jolla, CA).
All experiments were repeated at least three times and the data were
represented as the mean ± S.E.M. of three independent experiments.
3. Results
3.1. FP expression is highly induced during chondrocyte differentiation
To investigate the role of prostaglandin signaling in chondrocyte
differentiation, we assessed the expression levels of prostaglandin
receptors during chondrogenic differentiation of the ATDC5 cell line.
ATDC5 cells mimic multi-stages of chondrocyte differentiation from
chondroprogenitors to fully differentiated hypertrophic chondrocytes.
They proliferate and form cartilage nodules through cellular condensa-
tion when treated with insulin. These cells then differentiate into
cartilage-matrix synthesizing chondrocytes and eventually are converted
to pre-hypertrophic chondrocytes, followed by hypertrophy andminer-
alization [19]. Chondrocyte differentiation is associated with the
sequential expressions of types II (Col2A1) and X (Col10A1) collagen
mRNA,which aremarkers of cartilagematrix synthesis andhypertrophy,
respectively [20] (Fig. 1B). As shown in Fig. 1A, the mRNA levels of EP1,
EP3, and IP were almost undetectable whereas low levels of EP4 and
TP mRNA were seen during chondrogenic differentiation of ATDC5
cells. EP2 mRNA was highly expressed in undifferentiated (day 0) and
early differentiating chondrocytes (day 3), and then was gradually
decreased at the later stages of differentiation (days 7 and 12)
(Fig. 1A). In contrast, prostaglandin F2α receptor (FP) mRNA expression
was very low at days 0 and 3, but was dramatically induced at days 7
and 12 of chondrogenic differentiation (Fig. 1A). As shown in Fig. 1B,
induction of FPmRNAwas preceded by the expression of early differen-
tiation marker, Col2A1, and occurred before the expression of Col10A1,
a hypertrophic chondrocyte marker. This suggests that FP may play a
role in late chondrogenic differentiation. To determine whether the
induction of FP is a speciﬁc phenomenon in ATDC5 cells, the expression
of FP was examined in another cell line, C3H10T1/2, which is known to
differentiate into chondrocytes with Bmp-2 supplement [16]. As shown
in Fig. 1C, the expression of FP mRNA in C3H10T1/2 cell line was highly
increased during chondrogenic differentiation, showing an identical
pattern to that in ATDC5 cells. Because FP mRNA expression is highly
increased in differentiating chondrocytes, we examined FP mRNA
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reports, FP was expressed in the ovary, kidney, heart, and lung [21,22].
In addition, the cartilage exhibited high levels of FP mRNA (Fig. 1D).
These results suggest that the signaling through FP may play an impor-
tant role in chondrogenic differentiation in vivo and in vitro.3.2. Stimulation of FP signaling promotes chondrocyte differentiation
To investigate the functional signiﬁcance of increased FP expression
during chondrogenic differentiation, we generated an ATDC5 cell
line that stably expressed FP. ATDC5 cells were infected with the FP-
encoding lentivirus and selected in the presence of puromycin.
Puromycin-resistant clones were pooled for further experiments.
Western blot analysis showed that FLAG-tagged mouse FP was highly
expressed in the infected cells (Fig. 2A). To determine the effect of
increased FP expression on chondrocyte differentiation, mRNA levels
of differentiation markers were assessed by quantitative real-time
PCR. When the cells were induced to differentiate in the presence of
insulin, Col2A1 mRNA expression at days 7 and 12 was signiﬁcantly
up-regulated in FP over-expressing ATDC5 cells compared to that in
EGFP control cells (Fig. 2B). Likewise, expression of Col10A1 mRNA in
FP over-expressing ATDC5 cells increased signiﬁcantly at days 7 and
12 and the expression of Mmp13, another hypertrophy marker, was
increased at day 12 compared to those in control (Figs. 2C and D), sug-
gesting that an induction of FP may be associated with chondrogenic
differentiation.
As previously described [15], chondrogenic differentiation of ATDC5
cell line requires insulin. Stimulation with insulin resulted in the
differentiation of ATDC5 cells into chondrocytes and the formation of
cartilage nodules. Subsequently, these cells produce an extracellular
matrix that can be stained with alcian blue. To corroborate the role of
FP induction in chondrogenesis, we cultured control and FP over-
expressing ATDC5 cells in the media without insulin and examined
the expression of chondrogenic marker genes. Although less prominent
than in the presence of insulin, FP over-expressing ATDC5 cells
underwent chondrogenic differentiation even in the absence of insulin
and mimicked the insulin-inducible expression of marker genes. As
shown in Fig. 2E, the expression of Col2A1 mRNA at days 7 and 12 in
FP over-expressing ATDC5 cells cultured in the absence of insulin was
signiﬁcantly increased relative to that in the control cells. Furthermore,
the forced expression of FP resulted in a prominent increase in the level
of Col10A1 andMmp13mRNA, suggesting a possible role of FP in chon-
drocyte hypertrophy (Figs. 2F andG). In addition to themarker analysis,
an increased differentiation in FP over-expressing ATDC5 cells was
conﬁrmed by alcian blue staining. Control and FP over-expressing
ATDC5 cell lines were cultured for 12 days in the absence of insulin
and were stained with alcian blue. As shown in Fig. 2H (left panel), FP
over-expressing cells formed alcian blue-positive cartilage nodules
whereas control ATDC5 cells lacked the formation of cartilage nodules.
The quantitative analysis of alcian blue staining revealed that the
stain intensity in the FP over-expressing cells was 2.5 fold higher than
that in the control cells (Fig. 2H, right graph). These results suggest
that the induction of FP during chondrogenesis may promote and thus
be required for chondrogenic differentiation. Furthermore, stimulationFig. 6. FP signaling stimulates the expression of Bmp signaling components. (A)Western blot an
and FP over-expressing ATDC5 cells were cultured for 3 days in the absence of insulin and th
reprobed for total Smad1 and Smad2. The level of phospho-Smads were quantiﬁed and norm
quantiﬁcation normalized to total Smads. The graph (right panel) shows fold changes of norm
p b 0.01). (B) Western blot analysis of phospho-Smad 1/5 and phospho-Smad2 in control and
was stripped and reprobed for Smad1 and Smad2. The numbers on the Western blot represen
normalized phospho-Smad1/5 and phospho-Smad2 (compared with control) (n=3, ***: p b 0
cell lines was analyzed byWestern blot. The numbers shown on theWestern blot represent rel
the same blot. The graph (right panel) shows densitometric analysis ofWestern blot of Bmpr1a
FP knockdown ATDC5 cell line at day 7 of differentiation. The numbers shown on theWestern
actin bands from the same blot. The graph (right panel) shows fold changes of normalized Bmof FP signaling with its ligand, PGF2α, increased the expression of
genes related to chondrocyte differentiation. As shown in Fig. 2I,
treatment of ATDC5 cells with PGF2α highly induced the expression of
Acan1, Col2A1, and Col10A1 mRNAs. Taken together, these results
demonstrate that PGF2α signaling via FP stimulates chondrogenic
differentiation.
3.3. Knockdown of endogenous FP expression suppresses chondrogenic
differentiation
To examine the endogenous function of FP in chondrogenic differen-
tiation of ATDC5 cell line,we generated stable FP knockdownATDC5 cells
using shRNA. We infected ATDC5 cells with the lentivirus expressing
FP-speciﬁc shRNA. The resulting puromycin-resistant clones were
pooled and induced to differentiate in the presence of insulin. Since
FP expression was induced at days 7 and 12 during chondrogenic
differentiation (Figs. 1A and B), we isolated RNAs from the empty
vector-infected control and the FP shRNA-expressing ATDC5 cells at
day 12 of differentiation. As shown in Fig. 3A, the quantitative real-
time PCR analysis revealed that the expression of FP shRNA (FP shRNA
#1) resulted in a 75% reduction of FP mRNA levels compared to that
of the control cells. The reduction of FP by FP shRNA was conﬁrmed
by semi-quantitative RT-PCR (Fig. 3A, lower panel). The suppression
of FP induction by shRNA resulted in a 90% decrease in Col2A1 and
Col10A1 mRNA expression compared to that of the control cell line
(Figs. 3B and C), indicating that FP induction is required for
chondrogenic differentiation. The expression level of Mmp13 was also
highly suppressed in FP shRNA #1 cell line (Fig. 3D). Similarly, the
knockdown of FP caused a signiﬁcant decrease in the intensity of
alcian blue staining following differentiation for 15 days (Fig. 3E).
To avoid potential off-target effects, FP expression was knocked down
by another shRNA targeting in a different region of mouse FP (FP
shRNA #2). Although knockdown efﬁciency of the second shRNA
was lower compared to the ﬁrst shRNA, the levels of Col2A1 and
Col10A1 mRNA were signiﬁcantly reduced in the FP shRNA #2 cells
(Figs. 3B and C). These results suggest that the induction of FP
expression during chondrogenic differentiation is required for efﬁcient
chondrogenesis.
3.4. PGF2α enhances chondrocyte hypertrophy in metatarsal cartilage
rudiments
To further examine the effects of FP signaling on chondrogenic
differentiation, mouse fetal metatarsal cartilage rudiments were
isolated from the E15.5 fetus and were treated with 100 nM PGF2α for
6 days. Organ culture of the metatarsal cartilage rudiments allows for
the study of biological processes in a three-dimensional structure in
the context of native cell–cell and cell–extracellular matrix interactions
[17,23]. When E15.5 metatarsals, which are primarily composed of
immature chondrocytes, were cultured for 6 days, they underwent
longitudinal growth and development, showing a well-organized
growth plate composed of proliferating (PZ), pre-hypertrophic (PHZ),
and hypertrophic zones (HZ). As shown in Fig. 4A, PGF2α-treated rudi-
ments had extended HZ compared to that in vehicle-treated controlalysis of phospho-Smad 1/5 and phospho-Smad2 in control (EGFP) and FP cell line. Control
e total lysates were subjected to Western blot analysis. The membrane was stripped and
alized to total Smads using ImageJ software. The numbers on the Western blot represent
alized phospho-Smad1/5 and phospho-Smad2 (compared with EGFP control) (n= 3, **:
FP knockdown ATDC5 cell lines at day 7 of insulin-induced differentiation. The membrane
t quantiﬁcation normalized to total Smads. The graph (right panel) shows fold changes of
.001). (C) The expression of Bmpr1a during chondrogenic differentiation of control and FP
ative Bmpr1a levels obtained by normalizing densities of each band to β-actin bands from
protein (n=3, *: p b 0.05, **: p b 0.01). (D)Western blot analysis of Bmpr1a in control and
blot represent relative Bmpr1a levels obtained by normalizing densities of each band to β-
pr1a (compared with control) (n= 3, **: p b 0.05).
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vehicle- and PGF2α-treated rudiments (Fig. 4B). Histomorphometric
analysis showed that PGF2α treatment resulted in a 40% increase in the
ratio of HZ to total length compared to that in the vehicle-treated con-
trol (Fig. 4C), suggesting that PGF2α signaling stimulates hypertrophic
differentiation of chondrocytes in cartilage rudiments. To conﬁrm the
increase in the area of hypertrophic cartilage by PGF2α treatment,
immunohistochemical analysis of Col10A1 was performed in the meta-
tarsal cartilage sections. As shown in Fig. 4D, the Col10A1-stained region
was more extended in PGF2α-treated cartilage rudiments compared to
that in vehicle-treated cartilage. The quantitative analysis revealed
that the PGF2α resulted in a 36% increase in the length of Col10A1
expressing zone compared to control (Fig. 4E). In addition, PGF2a treat-
ment increased the expression of Mmp13 in the cartilage rudiments
(Fig. 4F). These results suggest that FP signalingmay stimulate chondro-
cyte hypertrophy.3.5. FP signaling up-regulates the expression of Bmp signaling components
It has been shown that insulin-induced chondrogenic differentiation
of ATDC5 cells requires Bmp autocrine signaling [24]. Tgf-β/Bmp
signaling pathways are two major signaling pathways that control
cartilage development and homeostasis [25–33]. Tgf-β/Bmp ligands
bind to type II receptors which then recruit the corresponding type I
serine/threonine kinase receptor. Upon ligand binding, Bmp type I
receptors phosphorylate Smad1/5/8, whereas Tgf-β type I receptors
activate Smad 2/3 [34]. It was demonstrated that exogenously added
Bmp can induce the differentiation of ATDC5 cells in the absence of
insulin [31]. Since stimulation of FP signaling induced the chondrogenic
differentiation of ATDC5 cells even in the absence of insulin, we
examined whether the stimulation of FP signaling is associated with
the alterations in Tgf-β/Bmp signaling. To determine the effect of FP
signaling on the levels of Tgf-β/Bmp ligands, control and FP over-
expressing ATDC5 cells were cultured in the media without insulin
and the quantitative real-time PCR analysis for Tgf-β/Bmp ligands was
conducted. Consistent with the previous reports [35], the levels of
Bmp-2 and Bmp-7 transcripts were undetectable (data not shown and
Supplementary Figure) in both control and FP over-expressing ATDC5
cells. As shown in Fig. 5A, FP expression resulted in a 2 fold increase in
basal level of Bmp-4 expression compared to control cells. Although a
1.5- to 2-fold increase of Bmp-4 mRNA levels at day 3 was detected in
FP over-expressing cells, there were no signiﬁcant differences in
Bmp-4 mRNA levels between the control and the FP over-expressing
cells at the later time points. However, the Bmp-6 gene exhibited a
differential expression pattern between the two cell lines. As shown in
Fig. 5B, FP expression resulted in a signiﬁcant increase in Bmp-6
mRNA levels compared to those in the control. Furthermore, incubation
with dorsomorphin, a selective inhibitor of Bmp signaling, suppressed
FP-induced increase in the level of Col2A1 and Col10A1 mRNA
(Figs. 5C and D), suggesting that FP may promote chondrogenic
differentiation by modulating Bmp signaling. To deﬁne the role of
endogenous FP on the synthesis of Bmp ligands, we cultured control
and FP knockdown ATDC5 cells in the presence of insulin and
determined the mRNA levels of Bmp ligands. Bmp-2 and Bmp-7
mRNAs were undetectable (Supplementary Figure) in control and FP
knockdown cells, while Bmp-4 mRNA was constitutively expressed at
all differentiation stages in both cell lines (Fig. 5E). However, knock-
down of FP resulted in the alteration of Bmp-6 mRNA expression. In
the control cell line, Bmp-6 mRNA was highly induced at days 7 and
12 (Fig. 5F), at which FP expression was observed (Figs. 1A and B).Fig. 7. PGF2α increases levels of phosphorylated Smad1/5/9 in metatarsal cartilage. (A and B)
treated with vehicle (A) or 100 nM PGF2α (B) for 6 days. The resting (RZ), proliferating zone
image. (C) Graphical presentation of phospho-Smad1/5/9 positive cells (n=3, *: p b 0.05). (D a
of the areas indicated by boxes. (F and G) High magniﬁcation images of proliferating, pre-hypeHowever, knockdown of FP resulted in a delay in Bmp-6 mRNA expres-
sion. Furthermore, the level of Bmp-6 mRNA was signiﬁcantly reduced
in FP knockdown cells compared to that of the control.
Next, we examined the phosphorylation status of Smads in control
and FP over-expressing ATDC5 cell lines. As shown in Fig. 6A, the level
of phospho-Smad1/5 was increased in FP over-expressing ATDC5 cells
even in the absence of insulin while the total amount of Smad1 protein
was not signiﬁcantly altered, suggesting that FP signaling resulted in
the activation of the Bmp pathway. Interestingly, the level of phospho-
Smad2 was slightly decreased in the FP over-expressing cell line. We
also determined the levels of phospho-Smads in FP knockdown cells
at day 7 of insulin-induced chondrogenic differentiation, when FP
mRNA expression begins to be observed (Figs. 1A and B). As shown in
Fig. 6B, knockdown of endogenous FP induction resulted in decreased
levels of phospho-Smad1/5 while it did not signiﬁcantly affect phospho-
Smad2 levels, suggesting that endogenous FP signaling is required for
activation of the Bmp pathway. Smad1/5 proteins are phosphorylated
by the heteromeric complexes of type II and type I Bmp receptors. It
has been shown that Bmpr1a, one of the type I Bmp receptors, and
Bmpr2, a type II Bmp receptor, are expressed in ATDC5 cells [35].
Since FP signaling appears to modulate phosphorylation of Smad1/5,
we examined whether the levels of Bmp receptors are regulated by
FP. As shown in Fig. 6C, Western blot analysis revealed that Bmpr1a
expression is increased in FP over-expressing ATDC5 cells compared
to the control cells. However, knockdown of FP expression reduced
the levels of Bmpr1a (Fig. 6D). Finally, to corroborate that PGF2α
signaling regulates the Bmp pathway, we determined whether PGF2α
treatment alters the expression of phospho-Smad1/5/9 in growth plates
of cartilage rudiments. Consistent with the previous reports [25,36],
phosphorylated Smad1/5/9 were detected in pre-hypertrophic and
hypertrophic chondrocytes of both the control and PGF2α-treated
rudiments. However, incubation with PGF2α caused a signiﬁcant
increase in the number of phospho-Smad1/5/9 positive chondrocytes
in the resting zone (RZ) while the chondrocytes in the RZ of control
rudiments rarely expressed phospho-Smad1/5/9 (Fig. 7). Taken together,
these results suggest that FP signaling is associated with the activation
of the Bmp pathway.4. Discussion
In this article, we have shown that FP expression is highly induced
during chondrocyte differentiation. We have deﬁned the functional sig-
niﬁcance of FP induction during chondrogenesis. Our data demonstrated
that FP expression stimulates and is required for efﬁcient chondrocyte
differentiation. In addition, our results suggest that FP signaling modu-
lates Bmp signaling.
During the chondrogenic differentiation of ATDC5 cells, EP2 and FP
mRNA levels are differentially regulated (Fig. 1A). EP2 expression was
high at days 0 and 3 of chondrogenic differentiation and gradually
decreased in the later stages of differentiation. This suggests that the
down-regulation of EP2 signaling may be associated with the onset of
differentiation in chondrocytes. In contrast, the basal level of FP was
very low. However, FP expressionwas highly induced in the later stages
of chondrogenesis, suggesting that sustained FP signaling may be
required for chondrogenic differentiation. Our results also suggest that
PGF2α signaling may be regulated by the levels of its receptor, FP, as
well as by the PGF2α level. Consistent with this notion, the expression
of FP mRNA has shown to be regulated by various stimuli. FP mRNA
expression in mouse skin was increased immediately after the phorbol
ester 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment, followedImmunohistochemical staining of phospho-Smad1/5/9 in metatarsal cartilage rudiments
and pre-hypertrophic (PZ & pre-HZ), and hypertrophic zone (HZ) were denoted in the
nd E) Highmagniﬁcation images of resting zone. Insets show highermagniﬁcation images
rtrophic, and hypertrophic zones.
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tion of pregnant mare serum gonadotropin (PMSG) increased the
ovarian FP mRNA level in mice [38].
Prostaglandin receptors have been implicated in chondrocyte
metabolism. It has been shown that PGE2 receptors (EP1–4) are
expressed in both growth plates and primary chondrocytes [39]. Stimu-
lation of human articular chondrocytes with PGE2 through the EP2
receptor suppressed proteoglycan accumulation and synthesis [40].
However, the role of FP in chondrocyte metabolism has not been
delineated. We demonstrated that knockdown of FP mRNA induction
interfered with chondrogenic differentiation while forced expression
of FP promotes differentiation, suggesting that induction of FP expres-
sion is required for chondrogenic differentiation. Further, our data sug-
gests that FP signaling may be involved in chondrocyte hypertrophy.
First, FP mRNA expression was observed before the expression of
Col10A1, a marker of hypertrophic chondrocytes, while it was preceded
by Col2A1 expression, suggesting that expression of Col10A1 may
require FP. In addition, FP overexpression or PGF2α treatment resulted
in a greater increase of Col10A1 relative to Col2A1 mRNA. Furthermore,
the incubation of metatarsal cartilage rudiments with PGF2α increased
the length of the hypertrophic zone which expresses Col10A1 and
Mmp13. Recently, expression of FPmRNAwas reported in hypertrophic
chondrocytes of growth plate cartilage [14], further suggesting a
putative role of FP in hypertrophic differentiation of chondrocytes. We
were not able to determine the expression of FP protein due to the
lack of reliable, commercially available FP antibodies. Therefore, FP
protein expression during chondrogenic differentiation or in cartilage
remains to be determined. In addition, the reported phenotypes of the
FP knockout mouse do not include any gross skeletal abnormalities
[41]. This suggests the possible in vivo redundancy of prostanoid recep-
tor signaling that controls chondrocyte differentiation. FP, EP1, and TP
are coupled to Gq proteins and act through an increase in calcium and
inositol triphosphate [42]. Therefore, it is possible that an increase in
the expression or sensitivity of another prostanoid receptor may com-
pensate for the lack of FP.
Several lines of reports have shown that prostaglandins regulate
expression of Bmps. For example, PGE2 has up-regulated the expression
of Bmp-7 mRNA and protein in vitro and in vivo, probably by post-
transcriptional mechanisms [43]. In addition, PGE2 has induced the
expression of Bmp-2 in human tendon stem cells [44]. We found that
Bmp-6 mRNA expression was up-regulated by the stimulation of FP
signaling but was suppressed by the inhibition of endogenous FP
expression, suggesting that FP may be involved in the regulation of the
Bmp-6 gene. Since FP signaling appears to be involved in chondrocyte
hypertrophy, it may be possible that the effect of FP on chondrocyte
differentiation is mediated via Bmp-6. In fact, exogenously added
Bmp-6 has shown to facilitate thephenotypic conversion of proliferating
ATDC5 cells to hypertrophic cells [45]. In addition, phospho-Smad1/5
levels were increased in FP over-expressing cells while its expression
was decreased in differentiating FP knockdown cells. Moreover,
incubation of cartilage rudiments with PGF2α increased the number of
phospho-Smad1/5/9 positive cells. Given that Smad1 plays a critical
role in chondrocyte hypertrophy [25], our results suggest that FP
signaling regulates hypertrophic differentiation of chondrocytes by
modulating Bmp signaling. In line with this notion, we found that an
inhibition of Bmp signaling by dorsomorphin suppressed FP-induced
chondrogenic differentiation and marker gene expression.
Our results also suggest the possible role of FP signaling in the path-
ogenesis of arthritis. Under normal conditions, chondrocytes in the
articular cartilage remain in a resting state and maintain extracellular
matrix integrity. However, some chondrocytes in OA-affected cartilages
lose their phenotype and undergo similar differentiation programs as
growth plate chondrocytes. As a result, affected articular chondrocytes
differentiate into hypertrophic chondrocytes and undergo apoptosis,
eventually leading to cartilage loss [46]. Increased expression of genes
related to chondrocyte hypertrophy including Col10A1 and Mmp13 isfrequently observed in OA-affected cartilages. We have shown that FP
signaling promotes and is required for the expression of hypertrophic
markers including Col10A1 and Mmp13. Additionally, we observed
that FP signaling stimulated Mmp13 promoter activity (data not
shown). Increased Mmp13 expression and activity in OA cartilage
have been suggested to play a critical role in the pathogenesis of OA.
Given the fact that PGF2α levels are elevated in OA-affected joint ﬂuid
[10], our ﬁndings suggest that increased FP signaling may accelerate
hypertrophic chondrocyte differentiation in OA-affected joints, contrib-
uting to the development and/or progression of OA. Future study will
deﬁne how FP signaling interacts with other signaling pathways
involved in cartilage development and diseases.
In summary, our study uncovered a novel regulatory role of FP
signaling on chondrocyte differentiation. Additionally, the ﬁndings in
this study provide a plausible mechanism for chondrocytes to respond
to various prostaglandins, whichmay allowus to developmore effective
treatment strategies for skeletal diseases while minimizing side effects.
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